Massive week coming, I’d be very surprised if #AVCT finished the day negative
And another at 16.03 could these be shorts closing?? If so we can expect a reversal #AVCT
1
6
2,502
Anyone an idea on those 3 trades about 2.6 million shares in total? #AVCT
Well, I would imagine those who took part in the last placing aren’t too impressed right now!! #AVCT
#AVCT more professional acknowledgment 😉
#AVCT am I the only one who thought we’d be getting some traction this week heading into ESMO? Obviously looking how the SP has flatlined I’m wrong, again!!
#AVCT I can’t reply to JT’s posts but he is 100% correct, anyone thinking a value in the low $billions are way way off the mark in my opinion
I’m a bit confused, when does trading start again, tomorrow or the 9th? Maybe I missed something in the RNS #AVCT
Am I the only one scratching my head thinking 68p WTF #AVCT
I did mention this a couple of weeks ago, why they had to wait though is beyond me #AVCT
Ok I know I’m going to get a bit of stick on this one but the price action tells me something we didn’t expect may be coming, a placement, now if this is to completely clear the loan then imo it’s a good move, clear the decks and move on. Ok bring on the abuse! #AVCT
Endpoints News is highly respected and considered one of the most influential, trusted news authorities in the biopharmaceutical industry. That’ll do #AVCT
Ok I know I’m going to get a bit of stick on this one but the price action tells me something we didn’t expect may be coming, a placement, now if this is to completely clear the loan then imo it’s a good move, clear the decks and move on. Ok bring on the abuse! #AVCT
Ok so no RNS, around 10 million shares traded over the last 2 days, too many to be retail imo, I’m totally flummoxed over this price action 🤷🏻♂️ #AVCT
This ➡️ 6103 systemic toxicity drops off a cliff, White blood cells unaffected (0% Neutropenia)
Blood platelets mostly untouched (5% Thrombocytopenia vs. 43% with exatecan)
The gut lining is spared (5% Nausea & Vomitingvs. 44% for Enhertu and 67% for conventional exatecan) #AVCT
Absolutely typical, as soon as #avct gets interesting @spreadexfins stop taking buy orders, this is the second time in a very short while they have done this, very frustrating!




